BIM
ARIA

BlackRock Investment Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

BlackRock Investment Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$8.3M Sell
667,499
-2,173
-0.3% -$26.2K 0.01% 1246
2016
Q3 		$9.17M Buy
669,672
+4,825
+0.7% +$48.5K 0.01% 1065
2016
Q2 		$4.91M Buy
664,847
+76,515
+13% +$574K 0.01% 1448
2016
Q1 		$3.76M Buy
588,332
+24,858
+4% +$139K ﹤0.01% 1566
2015
Q4 		$3.52M Buy
563,474
+1,732
+0.3% +$11.4K ﹤0.01% 1647
2015
Q3 		$3.28M Sell
561,742
-6,255
-1% -$48.2K ﹤0.01% 1682
2015
Q2 		$4.7M Buy
567,997
+111,846
+25% +$989K 0.01% 1547
2015
Q1 		$3.76M Buy
456,151
+7,231
+2% +$53.5K ﹤0.01% 1584
2014
Q4 		$3.08M Sell
448,920
-4,665
-1% -$29.2K ﹤0.01% 1713
2014
Q3 		$2.45M Buy
453,585
+2,286
+0.5% +$13.4K ﹤0.01% 1849
2014
Q2 		$2.88M Buy
451,299
+389,172
+626% +$2.68M ﹤0.01% 1794
2014
Q1 		$501K Sell
62,127
-910
-1% -$7.09K ﹤0.01% 2951
2013
Q4 		$430K Sell
63,037
-105,754
-63% -$571K ﹤0.01% 3018
2013
Q3 		$3.11M Buy
168,791
+92,357
+121% +$1.79M 0.01% 1622
2013
Q2 		$1.34M Buy
+76,434
New +$1.35M ﹤0.01% 2166

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

BlackRock Investment Management's ARIA Position: Q4 2016 in Review

BlackRock Investment Management reduced its Ariad Pharmaceuticals Inc (ARIA) stake by 0.32% in Q4 2016, selling an estimated $26.2K and leaving 667,499 shares worth $8.3M. The position accounts for 0.01% of the portfolio, ranked #1246.

BlackRock Investment Management first reported a position in ARIA in Q2 2013 and has held it in 15 quarters since. The position peaked at $9.17M in Q3 2016. 200 funds tracked by Wall St. Rank hold ARIA as of Q4 2016.

  • BlackRock Investment Management held 667,499 shares of Ariad Pharmaceuticals Inc worth $8.3M as of Q4 2016.
  • BlackRock Investment Management sold 2,173 Ariad Pharmaceuticals Inc shares in Q4 2016, an estimated $26.2K.
  • Ariad Pharmaceuticals Inc made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1246 holding.
  • BlackRock Investment Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Ariad Pharmaceuticals Inc position peaked at $9.17M in Q3 2016.
  • 200 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.